For documented multidrug-resistant gram-negative infections due to organisms proven or suspected to be susceptible to piperacillin-tazobactam except central nervous system (CNS) infections and for polymicrobial infections (eg, mixed aerobic & anaerobic infections) in which other agents have insufficient activity or are contraindicated due to toxic potential.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
